Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

InterMune Inc ITMN

Healthcare Biotechnology


NDAQ:ITMN - Post by User

InterMune Inc > Struggles
<< Previous
 Bullboard Posts
User Avatar Image
(0)
•••
Comment by gossipgirlon Jun 21, 2008 12:23pm
725 Views
Post# 15212755

RE: Struggles

RE: StrugglesEven with its decent cash position, the financials are not looking good. Increasing expenses and decreasing revenues, with no indication of whether or not their drugs under development will get approved, Intermune just isn't looking good right now.
<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities